logo
Scots woman says trying to lose weight was like a 'full-time job'

Scots woman says trying to lose weight was like a 'full-time job'

Daily Record01-06-2025

Healthcare worker Connie Bulloch, 28, has now shed five stone after hearing other success stories.
A woman who lost five stone while on Mounjaro says weight management used to be "like a full-time job."
Healthcare worker Connie Bulloch, 28, from Cambuslang had struggled with her weight for years - but after undergoing an unrelated operation last March and gaining a stone and a half, she was desperate to find a solution.

Despite watching her diet and regularly attending sessions with a personal trainer, Connie struggled to shift the weight, and began looking into medical interventions.

At 15 stone 10lbs, she was too light to qualify for weight loss surgery on the NHS, and she worried that travelling abroad for an operation would be too risky - but after hearing success stories with weight loss drug Mounjaro, she began the process of obtaining a private prescription.

Join the Daily Record WhatsApp community!
Get the latest news sent straight to your messages by joining our WhatsApp community today.
You'll receive daily updates on breaking news as well as the top headlines across Scotland.
No one will be able to see who is signed up and no one can send messages except the Daily Record team.
All you have to do is click here if you're on mobile, select 'Join Community' and you're in!
If you're on a desktop, simply scan the QR code above with your phone and click 'Join Community'.
We also treat our community members to special offers, promotions, and adverts from us and our partners. If you don't like our community, you can check out any time you like.
To leave our community click on the name at the top of your screen and choose 'exit group'.
If you're curious, you can read our Privacy Notice.
"I was working with my personal trainer, and had been for two years," said Connie.
"I was maintaining weight, or sometimes even putting on a few pounds, and I just wasn't happy with it. It was like a full-time job - constantly having to go to the gym, constantly watching what I'm eating.

"If I'd eat a takeaway, I'd have put on two pounds by the end of the weekend. Then I went for an operation around March last year, and it took me a while to recover from that - and I put on a stone and a half.
"It got to me - it was one of those things where I needed the weight off and I needed to do something now. I was looking at surgeries abroad to help me lose the weight, but it didn't seem reasonable for me.
"The NHS wouldn't accept me for the surgery waitlist because I wasn't heavy enough. I was thinking about it for about a month. I've got kidney disease, so that was one of the main concerns. If it was going to affect my kidneys, it wouldn't be worth it.

"At the beginning, I was convinced I'd be the person that dies taking this drug, but after a while, I saw lots more people trying it and having success stories, so I thought I'd give it a go. I did it through an online pharmacy.
"I filled out the form, took pictures of my body, and took a picture of the scale with my weight on it. I sent that away, and they got back to me within a few days to say that I'd been accepted, and the prescription would be sent out with 24 hour delivery."

Mounjaro, a brand name for weight loss drug tirzepatide, works by mimicking the hormones released by the body after a meal, so the user experiences the feeling of fullness and encourages the body to burn fat.
It is only available through private prescriptions in the UK, and Connie - despite being nervous about the side effects - decided to fork out £180 for her first month of four injections.
In her first week, she lost one pound - and after a month on a 2.5mg dosage, she upped her dosage to 5mg. However, the side effects became too intense, so she quickly reduced her dosage, and has since maintained the lower dosage for nearly a full year.

"At the beginning, I didn't think it was going to work for me," she said. "I'd heard about people losing five or six pounds a week on it, and on my very first week, I only lost a pound.
"A pound is great, but I think I was just expecting more from it - but I've always been a slow loser. I thought at the beginning that I'd have to go up a dose every four weeks, so I went up to 5mg, but I was really unwell with it.
"I couldn't eat and I was vomiting, so I went back down to the lower dose and stayed on that."

Connie has now lost five stone and three pounds while on Mounjaro, and hopes to lose a further stone. She has begun sharing her story in the hopes of reducing the stigma around medical intervention for weight loss - but warns that the drug isn't an instant cure.
"It'll be a year next month that I've been on it, and it's been really good," she said. "I still need to use some of my willpower because I'm not on the higher doses, but I've been able to lose or maintain my weight - I've never gained anything in the year I've done it.
"I think a lot of people are scared to try it at the beginning, and I felt like that myself. I think hearing more success stories instead of all the negatives is really good.

"There's a lot of women in the same boat as me, where it's maybe hormonal reasons why they can't lose weight or they struggle to keep weight off. This has made it so much easier for me.
"My mindset is much better - but it's not a cure. I still have bad days where I look in the mirror and see who I was five stone ago. Some days I really love myself and some days I still hate myself, so it's not cured that side of things."
Connie believes that there is an unfair stigma around the drug - but urges anyone considering it to ensure they've exhausted all non-medical routes to weight loss first.
"There are lots of people out there that find it easy to keep weight off, but there are a lot more factors that go into why people are overweight. This will just make it so much more simple for people.
"I think as long as people have tried everything non-medical, like eating well and exercising, and they're still not able to keep the weight off, then this is definitely the right thing for them - but it's important to still hold yourself responsible and source it properly."

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NHS urges many people between 25 and 64 to put on key phone alert
NHS urges many people between 25 and 64 to put on key phone alert

Daily Mirror

time28 minutes ago

  • Daily Mirror

NHS urges many people between 25 and 64 to put on key phone alert

Invitations to specific health examinations are now being issued through the NHS mobile app - here's what you need to know Certain Android and iPhone users aged 25 and 64 are encouraged to download the NHS app for important updates. This specifically regards women, trans people and anyone else with a cervix, which describes the neck of the uterus. This morning, the NHS issued a crucial alert about its mobile app on X, formerly Twitter. It stressed: "Cervical screening invitations are now being sent through the NHS App for women and people with a cervix between the ages of 25 and 64. ‌ "One - Download the NHS App. Two - Turn on notifications. Three - Book and attend your appointment, when invited." Cervical screenings, commonly called smear tests, are conducted to assess the health of the cervix and aid in preventing cancer. ‌ Generally, the examination takes around five minutes and involves undressing from the waist down before lying on a bed. A nurse will then insert a tube-shaped speculum into the vagina and expand it to visualise the cervix, from which cell samples will be collected using a small brush. Medical professionals are particularly interested in types of 'human papillomavirus (HPV)', a widespread group of viruses that may lead to changes in the cervix. HPV spreads through multiple means, including sexual activity, skin-to-skin contact in the genital area, and sharing sex toys. Although the body can eliminate HPV without difficulty, certain types may persist for an extended period. In severe instances, high-risk HPV types could lead to genital warts or cervical cancer. "Cervical screening checks the health of your cervix and helps find any abnormal changes before they can turn into cancer," further NHS guidance explains. "It's not a test for cancer, it's a test to help prevent cancer. Cervical screening checks a sample of cells from your cervix for certain types of human papillomavirus (HPV). "These types of HPV can cause abnormal changes to the cells in your cervix and are called 'high risk' types of HPV. If high-risk types of HPV are found during screening, the sample of cells is also checked for abnormal cell changes. If abnormal cells are found, they can be treated so they do not get a chance to turn into cervical cancer." ‌ While 25 to 49-year-olds are typically invited to take a screening every three years, 50 to 64-year-olds are invited every five years. Anyone aged 65 or above may be asked if a recent examination was abnormal. Invitations are sent through the NHS app, as well as via text or mail. Am I at risk of cervical cancer? People with a cervix might be at risk of cervical cancer if they have engaged in 'any kind of sexual contact'. This includes: ‌ Vaginal, oral or anal sex Any skin-to-skin contact with the genital area Sharing sex toys This also applies in the following cases: You have only ever had one sexual partner, or you've had the same partner for a long time You are lesbian or bisexual You are a trans man with a cervix You have received the HPV vaccine You have undergone a partial hysterectomy that did not remove all of your cervix

Who is eligible for Mounjaro as weight loss jab becomes available from GPs?
Who is eligible for Mounjaro as weight loss jab becomes available from GPs?

Daily Record

time28 minutes ago

  • Daily Record

Who is eligible for Mounjaro as weight loss jab becomes available from GPs?

Here's who will be able to get Mounjaro, that treats types 2 diabetes and aids weight loss, on the NHS Weight-loss injections have surged in popularity over the last couple of years, fuelled by celebrity endorsements and social media exposure. And one jab that's capturing public attention and dominating headlines is Mounjaro. Tirzepatide, to give the treatment its medical name, is a prescription injectable medication designed to help adults with type 2 diabetes better manage their blood sugar levels. ‌ When combined with a healthy diet and regular exercise, it can significantly improve glucose control, supporting a more balanced approach to diabetes management. ‌ While originally developed to manage type 2 diabetes, Mounjaro has been licensed in the UK to treat obesity since November 2024, and is effective in helping patients achieve significant weight loss. Mounjaro received approval from NICE (National Institute for Health and Care Excellence) for treating obesity in England, Wales and Northern Ireland. Scotland had already approved Tirzepatide for obesity treatment through the Scottish Medicines Consortium, leading the way in making this medication available to patients. But as of today, Monday, June 23, GPs in England will be able to prescribe weight loss jabs for the first time on the NHS, as the health service begins its mass rollout. Some 220,000 people with the "greatest need" are expected to receive Mounjaro, made by pharmaceutical company Lilly, through the NHS over the next three years. ‌ So, amid the recent change, who is actually eligible for Mounjaro? According to NHS England, the first group of patients who will be able to get the jab from their GP or a community clinic, will be those most in need. In the first year of the programme, the drug will be offered to people with a body mass index (BMI) score of more than 40 who have at least four other health problems linked to obesity, such as: type 2 diabetes; high blood pressure; heart disease; and obstructive sleep apnoea. ‌ It was previously only accessible to patients through a special weight loss service, to severely obese people who also suffer from a range of other health problems. People will also get "wrap-around" care - including support with exercising and following a healthy diet, for example. But prescriptions for the drug will not necessarily be available from all local GPs, according to the BBC. In some cases, they will come from other primary care services. ‌ Some GP practices have issued notices on their websites saying very few patients on their lists, external will qualify for the medicine straight away and if anyone doesn't meet the criteria, they should not book an appointment. What's more, according to the Company Chemists' Association, the trade association for large pharmacies, it is not looking too promising that all patients who want Mounjaro and meet the criteria will get it straight away. Chief executive Malcolm Harrison said "it is unlikely that the planned GP provision will be sufficient to meet patient demand". ‌ The drug is usually delivered through a self-administered weekly injection which a doctor or nurse will show patients how to use, the NHS website says. Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News has established. Here, health boards make decisions on which medicines are available in their areas. In the same breath that we talk about people who are eligible for Mounjaro, there are groups who cannot take it. Mounjaro is not recommended for those who are pregnant or planning to get pregnant, breastfeeding or have certain health conditions, according to the NHS. For those taking the contraceptive pill and using Tirzepatide, the NHS recommends using an additional method of contraception, such as a condom, for the first four weeks of treatment and for four weeks after each dose increase as the contraceptive pill may not be absorbed by the body during this time. Join the Daily Record WhatsApp community!

National investigation into maternity care announced
National investigation into maternity care announced

BBC News

time35 minutes ago

  • BBC News

National investigation into maternity care announced

Health Secretary Wes Streeting has announced a national investigation into maternity care in "rapid" inquiry will urgently look at the worst-performing maternity and neonatal services in the country, including Leeds, Sussex, Gloucester, and Mid and South has met parents who have lost babies in a series of maternity scandals at some NHS trusts and said the investigation would "make sure these families get the truth and the accountability they deserve". It will begin this summer and report back by December 2025. The review will look across the entire maternity system, bringing together the findings of past reviews into a clear national set of actions to ensure every woman and baby receives safe, high-quality and compassionate the announcement on Monday, Streeting apologised on behalf of the NHS to those families who had suffered avoidable comes after a series of maternity scandals, including in Morecambe Bay, East Kent, Shrewsbury and Telford and said the review would be co-produced with the victims of maternity scandals, giving families a voice into how the inquiry is said he wants to ensure "no parent or baby is ever let down again".

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store